Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-12-2019 | Inflammatory Disorders

Overexpression of fractalkine and its histopathological characteristics in primary pterygium

Authors: Meydan Turan, Gulay Turan

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 12/2019

Abstract

Purpose

This study aimed to evaluate the differences in the expressions of fractalkine in normal bulbar conjunctiva and primary pterygium tissues.

Methods

The study included 48 patients who had been operated on for primary pterygium. Histopathologically, the presence of epithelial atypia, epithelial hyperplasia, goblet cell hyperplasia, epithelial lymphocytic exocytosis, stromal inflammation, mast cell count, and stromal vascularity were evaluated in the primary pterygium tissues. An immunohistochemical fractalkine stain was applied to the primary pterygium tissue samples and normal bulbar conjunctival tissue samples.

Results

Primary pterygium and normal bulbar conjunctival tissue samples were histopathologically analyzed. Epithelial atypia, epithelial hyperplasia, epithelial lymphocytic exocytosis, stromal inflammation, stromal vascularity, and mast cell count were found to be significantly higher in the primary pterygium (p = 0.001, p = 0.002, p = 0.024, p = 0.007, p = 0.024, and p = 0.013, respectively). When evaluated in terms of fractalkine expression, the epithelial, vascular endothelial, and inflammatory cells were significantly higher in the primary pterygium (p ≤ 0.001, p = 0.002, p = 0.001, respectively). Moreover, compared to the normal bulbar conjunctiva, Ki-67 expression was significantly higher in the primary pterygium tissue samples.

Conclusion

Fractalkine might play a key role in the etiopathogenesis of pterygium. Fractalkine may be important in developing new treatment approaches.

Di Girolamo N, Chui J, Coroneo MT et al (2004) Pathogenesis of pterygia: role of cytokines, growth factors and matrix metalloproteinases. Prog Retin Eye Res 23:195–228. https://doi.org/10.1016/j.preteyeres.2004.02.002 CrossRefPubMed

Sekundo W, Droutsas K, Cursiefen C (2010) Operative techniques for surgical treatment of primary and recurrent pterygia. Ophthalmologe 107:525–528. https://doi.org/10.1007/s00347-009-2099-6 CrossRefPubMed

Dzunic B, Jovanovic P, Zlatanovic G et al (2010) Comparative analysis of histopathological and clinical characteristics of pterygium. Vojnosanit Pregl 67:159–157. https://doi.org/10.4103/2008-322X.183917 CrossRefPubMed

Golu T, Mogoanta L, Streba CT et al (2011) Pterygium: histological and immunohistochemical aspects. Romanian J Morphol Embryol 52:153–158

Kase S, Osaki M, Jin XH et al (2007) Increased expression of erythropoietin receptor in human pterygial tissues. Int J Mol Med 20:699–702. https://doi.org/10.3892/ijmm.20.5.699 CrossRefPubMed

Kase S, Takahashi S, Sato I et al (2007) Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium. Br J Ophthalmol 91:958–961. https://doi.org/10.1136/bjo.2006.110387 CrossRefPubMed

Tan DT, Liu YP, Sun L (2000) Flow cytometry measurements of DNA content in primary and recurrent pterygia. Invest Ophthalmol Vis Sci 41:1684–1686PubMed

D’Haese JG, Demir IE, Friess H et al (2010) Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. Expert Opin Ther Targets 14:207–219. https://doi.org/10.1517/14728220903540265 CrossRefPubMed

Usta A, Turan G, Sancakli Usta C et al (2018) Placental fractalkine immunoreactivity in preeclampsia and its correlation with histopathological changes in the placenta and adverse pregnancy outcomes. J Matern Fetal Neonatal Med 10:1–10. https://doi.org/10.1080/14767058.2018.1505854 CrossRef

10.

Ruth JH, Volin MV, Haines GK et al (2001) Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum 44:1568–1581. https://doi.org/10.1002/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO;2-1 CrossRefPubMed

11.

Ruze A, Zhao Y, Li H et al (2018) Low shear stress upregulates the expression of fractalkine through the activation of mitogen-activated protein kinases in endothelial cells. Blood Coagul Fibrinolysis 29:361–368. https://doi.org/10.1097/MBC.0000000000000701 CrossRefPubMedPubMedCentral

12.

Sindhu S, Akhter N, Arefanian H et al (2017) Increased circulatory levels of fractalkine (CX3CL1) are associated with inflammatory chemokines and cytokines in individuals with type-2 diabetes. J Diabetes Metab Disord 16:15. https://doi.org/10.1186/s40200-017-0297-3 CrossRefPubMedPubMedCentral

13.

Siwetz M, Dieber-Rotheneder M, Cervar-Zivkovic M et al (2015) Placental fractalkine is up-regulated in severe early-onset preeclampsia. Am J Pathol 185:1334–1343. https://doi.org/10.1016/j.ajpath.2015.01.019 CrossRefPubMedPubMedCentral

14.

Zhou B, Xu H, Ni K et al (2016) Expression of chemokine XCL2 and CX3CL1 in lung cancer. Med Sci Monit 22:1560–1565. https://doi.org/10.12659/MSM.895985 CrossRefPubMedPubMedCentral

15.

Zou Y, Li Y, Lu L et al (2013) Correlation of fractalkine concentrations in serum and synovial fluid with the radiographic severity of knee osteoarthritis. Ann Clin Biochem 50:571–575. https://doi.org/10.1177/0004563213480494 CrossRefPubMed

16.

Wojdasiewicz P, Poniatowski LA, Kotela A et al (2014) The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis. Arch Immunol Ther Exp 62:395–403. https://doi.org/10.1007/s00005-014-0275-0 CrossRef

17.

Hannan NJ, Salamonsen LA (2008) CX3CL1 and CCL14 regulate extracellular matrix and adhesion molecules in the trophoblast: potential roles in human embryo implantation. Biol Reprod 79:58–65. https://doi.org/10.1095/biolreprod.107.066480 CrossRefPubMed

18.

Safi H, Kheirkhah A, Mahbod M et al (2016) Correlations Between Histopathologic Changes and Clinical Features in Pterygia. J Ophthalmic Vis Res 11:153–158. https://doi.org/10.4103/2008-322X.183917 CrossRefPubMedPubMedCentral

19.

Robinson LA, Nataraj C, Thomas DW et al (2000) A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol 165:6067–6072. https://doi.org/10.4049/jimmunol.165.11.6067 CrossRefPubMed

20.

Raychaudhuri SP, Jiang WY, Farber EM (2001) Cellular localization of fractalkine at sites of inflammation: antigen-presenting cells in psoriasis express high levels of fractalkine. Br J Dermatol 144:1105–1113. https://doi.org/10.1046/j.1365-2133.2001.04219.x CrossRefPubMed

21.

Rimaniol AC, Till SJ, Garcia G et al (2003) The CX3C chemokine fractalkine in allergic asthma and rhinitis. J Allergy Clin Immunol 112:1139–1146. https://doi.org/10.1016/j.jaci.2003.09.041 CrossRefPubMed

22.

Efsen E, Grappone C, DeFranco RM et al (2002) Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. J Hepatol 37:39–47. https://doi.org/10.1016/S0168-8278(02)00065-X CrossRefPubMed

23.

Kobayashi T, Okamoto S, Iwakami Y et al (2007) Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes. Inflamm Bowel Dis 13:837–846. https://doi.org/10.1002/ibd.20113 CrossRefPubMed

24.

Silverman MD, Zamora DO, Pan Y et al (2007) Constitutive and inflammatory mediator-regulated Fractalkine expression in human ocular tissues and cultured cells. Invest Ophthalmol Vis Sci 44:1608–1615. https://doi.org/10.1167/iovs.02-0233 CrossRef

25.

Rosenbaum JT, Becker MD, Smith JR (2000) Toward new therapies for ocular inflammation [in Spanish]. Arch Soc Esp Oftalmol 75:511–514PubMed

26.

Magone MT, Whitcup SM (1999) Mechanisms of intraocular inflammation. Chem Immunol 73:90–119. https://doi.org/10.1159/000058742 CrossRefPubMed

27.

Egwuagu CE, Sztein J, Mahdi RM et al (1999) IFN-gamma increases the severity and accelerates the onset of experimental autoimmune uveitis in transgenic rats. J Immunol 162:510–517PubMed

28.

Singh VK, Rai G (2001) Cytokines in posterior uveitis: an update. Immunol Res 23:59–74. https://doi.org/10.1385/IR:23:1:59 CrossRefPubMed

29.

Lacomba MS, Martin CM, Chamond RR et al (2000) Aqueous and serum interferon gamma, interleukin (IL) 2, IL-4, and IL-10 in patients with uveitis. Arch Ophthalmol 118:768–772. https://doi.org/10.1001/archopht.118.6.768 CrossRefPubMed

30.

Fraticelli P, Sironi M, Bianchi G et al (2001) Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 107:1173–1181. https://doi.org/10.1172/JCI11517 CrossRefPubMedPubMedCentral

31.

Enriquez-de-Salamanca A, Castellanos E, Stern ME et al (2010) Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis 16:862–873 <http://www.molvis.org/molvis/v16/a96>PubMedPubMedCentral

32.

Denoyer A, Godefroy D, Celerier I et al (2012) CX3CL1 expression in the conjunctiva is involved in immune cell trafficking during toxic ocular surface inflammation. Mucosal Immunol 5:702–711. https://doi.org/10.1038/mi.2012.43 CrossRefPubMed

33.

Chui J, Coroneo MT, Tat LT et al (2011) Ophthalmic pterygium: a stem cell disorder with premalignant features. Am J Pathol 178:817–827. https://doi.org/10.1016/j.ajpath.2010.10.037 CrossRefPubMedPubMedCentral

34.

Butrus SI, Ashraf MF, Laby DM et al (1995) Increased numbers of mast cells in pterygia. Am J Ophthalmol 119:236–237. https://doi.org/10.1016/S0002-9394(14)73882-6 CrossRefPubMed

35.

Zhou WP, Zhu YF, Zhang B et al (2016) The role of ultraviolet radiation in the pathogenesis of pterygia (review). Mol Med Rep 14:3–15. https://doi.org/10.3892/mmr.2016.5223 CrossRefPubMed

36.

Pahl HL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18:6853–6866. https://doi.org/10.1038/sj.onc.1203239 CrossRef

37.

Kennedy M, Kim KH, Harten B at al. (1997) Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells. Invest Ophthalmol Vis Sci 38:2483–2491PubMed

38.

Dong Y, Kase S, Dong Z et al (2016) Regulation of vascular endothelial growth factor-C by tumor necrosis factor-α in the conjunctiva and pterygium. Int J Mol Med 38:545–550. https://doi.org/10.3892/ijmm.2016.2647 CrossRefPubMed

39.

Ljubojevic V, Gajanin R, Amidzic L et al (2016) The expression and significance of p53 protein and Ki-67 protein in pterygium. Vojnosanit Pregl 73:16–20. https://doi.org/10.2298/VSP140428124L CrossRefPubMed

Title: Overexpression of fractalkine and its histopathological characteristics in primary pterygium
Authors: Meydan Turan
Gulay Turan
Publication date: 01-12-2019
Publisher: Springer Berlin Heidelberg
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 12/2019
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-019-04463-3

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Overexpression of fractalkine and its histopathological characteristics in primary pterygium

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 12/2019

Natural history of diabetic macular edema and factors predicting outcomes in sham-treated patients (MEAD study)

Evaluation of disk halo size after small incision lenticule extraction (SMILE)

Authors’ reply to: Using anterior segment optical coherence tomography to compare the smoothness of anterior iris surface between two eyes in unilateral Fuchs’ uveitis syndrome

The effect of estrogen and progesterone on porcine corneal biomechanical properties

Comparison of refractive outcomes using conventional keratometry or total keratometry for IOL power calculation in cataract surgery

Long-term endothelial cell loss with the iris-claw intraocular phakic lenses (Artisan®)